FB Financial (NYSE:FBK) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.79 by 7.59 percent. This is a 4.49 percent decrease over earnings of $0.89 per share from the same period last year.
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Lowers Price Target to $54
HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price target from $60 to $54.
